Clene to Provide Virtual Corporate Update at Emerging Growth Conference on April 17, 2025
Clene (CLNN) to deliver a virtual corporate update at the Emerging Growth Conference on April 17, 2025. Learn more about the company's advancements in treating neurodegenerative diseases like ALS and MS.
This news matters as it highlights Clene's progress in developing treatments for neurodegenerative diseases like ALS and MS. Investors and individuals interested in advancements in medical research should pay attention to Clene's presentation at the Emerging Growth Conference.
